Daliresp 250 ug/1 (Roflumilast TABLET) 250 ug/1

Daliresp 250 µg tablets contain roflumilast, a medication used to manage chronic obstructive pulmonary disease (COPD). This oral treatment helps reduce inflammation in the lungs, aiding in symptom management. Learn more about roflumilast and its uses here.

Strength

250 ug/1

Pack Size

1 BLISTER PACK in 1 BOX, UNIT-DOSE (0310-0088-28) / 28 TABLET in 1 BLISTER PACK

Manufacturer / TM Owner

AstraZeneca Pharmaceuticals LP

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Daliresp 250 µg tablets are primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). Roflumilast, the active ingredient, works by reducing inflammation in the lungs, which can help improve breathing and reduce flare-ups. This medication is often prescribed for individuals with severe COPD who experience frequent exacerbations. What is Daliresp used for? It is designed to manage symptoms and improve quality of life for those with this chronic condition.

Side Effects

Common effects of Daliresp 250 µg tablets may include headaches, diarrhea, nausea, and weight loss. Some individuals might also experience insomnia or dizziness. These effects vary from person to person and are not experienced by everyone who takes the medication. If any effects are severe or persistent, it is important to consult a healthcare provider.

Precautions & Warnings

Daliresp 250 µg tablets should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication may not be suitable for everyone, especially those with certain medical conditions or allergies. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Avoid Interactions

Daliresp 250 µg tablets may interact with other medications, including those that are metabolized by the liver's cytochrome P450 enzymes. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Additionally, certain foods or supplements may also interact with roflumilast, so it is advisable to consult a healthcare professional for personalized advice.

References

Frequently Asked Questions

Daliresp is used for the maintenance treatment of chronic obstructive pulmonary disease (COPD) to reduce inflammation and improve breathing.

Daliresp tablets are taken orally, typically once daily. Follow the specific instructions provided by your healthcare provider.

Common side effects may include headaches, diarrhea, nausea, weight loss, insomnia, and dizziness.

Daliresp may interact with other medications. Consult your healthcare provider to ensure safe concurrent use.

Daliresp may not be suitable for individuals with certain medical conditions or allergies. Always consult a healthcare provider.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.